These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19498198)

  • 41. Implications of detection of foramen ovale patent after cryptogenic ischemic stroke.
    Marinheiro R; Parreira L; Amador P; Silvestre I; Antunes C; Caria R
    J Echocardiogr; 2019 Mar; 17(1):44-51. PubMed ID: 30008156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism.
    Wintzer-Wehekind J; Alperi A; Houde C; Côté JM; Asmarats L; Côté M; Rodés-Cabau J
    J Am Coll Cardiol; 2019 Jan; 73(3):278-287. PubMed ID: 30678757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex differences in cryptogenic stroke with patent foramen ovale.
    Nedeltchev K; Wiedmer S; Schwerzmann M; Windecker S; Haefeli T; Meier B; Mattle HP; Arnold M
    Am Heart J; 2008 Sep; 156(3):461-5. PubMed ID: 18760126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patent foramen ovale and atrial septal aneurysm can cause ischemic stroke in patients with antiphospholipid syndrome.
    Tanaka Y; Ueno Y; Miyamoto N; Shimada Y; Tanaka R; Hattori N; Urabe T
    J Neurol; 2013 Jan; 260(1):189-96. PubMed ID: 22836909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiac and Echocardiographic Markers in Cryptogenic Stroke with Incidental Patent Foramen Ovale.
    Tateishi Y; Ueno Y; Tsujino A; Kuriki A; Kamiya Y; Shimizu T; Doijiri R; Yamaguchi E; Kikuno M; Shimada Y; Takekawa H; Koga M; Ihara M; Hirata K; Hasegawa Y; Toyoda K; Hattori N; Urabe T;
    J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105892. PubMed ID: 34107415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Morphological and functional characteristics of patent foramen ovale and their embolic implications.
    De Castro S; Cartoni D; Fiorelli M; Rasura M; Anzini A; Zanette EM; Beccia M; Colonnese C; Fedele F; Fieschi C; Pandian NG
    Stroke; 2000 Oct; 31(10):2407-13. PubMed ID: 11022072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure.
    Faggiano P; Frattini S; Piovesana P; Lorusso R; Chiari E; Scolari F; Padovani A; Cas LD
    Int J Cardiol; 2012 Apr; 156(1):47-52. PubMed ID: 21112103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcatheter closure of patent foramen ovale in patients older than 60 years of age with cryptogenic embolism.
    Wintzer-Wehekind J; Alperi A; Houde C; Côté JM; Del Val D; Côté M; Rodés-Cabau J
    Rev Esp Cardiol (Engl Ed); 2020 Mar; 73(3):219-224. PubMed ID: 31585849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale.
    Merkler AE; Gialdini G; Yaghi S; Okin PM; Iadecola C; Navi BB; Kamel H
    Stroke; 2017 Nov; 48(11):3073-3077. PubMed ID: 28939677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of patent foramen ovale in patients with ischemic stroke on prospective ECG-gated cardiac CT compared to transthoracic echocardiography.
    Rinkel LA; Bouma BJ; Boekholdt SM; Beemsterboer CFP; Lobé NHJ; Beenen LFM; Marquering HA; Majoie CBLM; Roos YBWEM; van Randen A; Planken RN; Coutinho JM
    J Neurol; 2023 Jul; 270(7):3537-3542. PubMed ID: 37027020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults).
    Pezzini A; Grassi M; Lodigiani C; Patella R; Gandolfo C; Zini A; DeLodovici ML; Paciaroni M; Del Sette M; Toriello A; Musolino R; Calabrò RS; Bovi P; Adami A; Silvestrelli G; Sessa M; Cavallini A; Marcheselli S; Marco Bonifati D; Checcarelli N; Tancredi L; Chiti A; Del Zotto E; Tomelleri G; Spalloni A; Giorli E; Costa P; Giacalone G; Ferrazzi P; Poli L; Morotti A; Piras V; Rasura M; Simone AM; Gamba M; Cerrato P; Zedde ML; Micieli G; Melis M; Massucco D; Guido D; De Giuli V; Bonaiti S; D'Amore C; La Starza S; Iacoviello L; Padovani A;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients.
    Han Y; Zhang X; Zhang F
    J Cardiothorac Surg; 2020 Jan; 15(1):11. PubMed ID: 31918738
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials.
    Schulze V; Lin Y; Karathanos A; Brockmeyer M; Zeus T; Polzin A; Perings S; Kelm M; Wolff G
    Clin Res Cardiol; 2018 Sep; 107(9):745-755. PubMed ID: 29500568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis.
    Ntaios G; Papavasileiou V; Sagris D; Makaritsis K; Vemmos K; Steiner T; Michel P
    Stroke; 2018 Feb; 49(2):412-418. PubMed ID: 29335335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new theory of cryptogenic stroke and its relationship to patent foramen ovale; or, the puzzle of the missing extra risk.
    Eggers AE
    Med Hypotheses; 2006; 67(5):1072-5. PubMed ID: 16814938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of atrial septal abnormalities in older patients with cryptogenic ischemic stroke or transient ischemic attack.
    Force M; Massabuau P; Larrue V
    Clin Neurol Neurosurg; 2008 Sep; 110(8):779-83. PubMed ID: 18534743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patent Foramen Ovale Closure in Older Patients With Stroke: Patient Selection for Trial Feasibility.
    Wang AY; Rothwell PM; Nelson J; Saver JL; Kasner SE; Carroll J; Mas JL; Derumeaux G; Chatellier G; Furlan AJ; Herrmann HC; Jüni P; Kim JS; Koethe B; Lee PH; Lefebvre B; Mattle HP; Meier B; Reisman M; Smalling RW; Sondergaard L; Song JK; Di Angelantonio E; DiTullio M; Elkind MSV; Homma S; Jaigobin C; Michel P; Mono ML; Nedeltchev K; Papetti F; Serena J; Weimar C; Li L; Mazzucco S; Silver LE; van Klaveren D; Thaler DE; Kent DM
    Neurology; 2024 May; 102(10):e209388. PubMed ID: 38701403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
    Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
    N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of medical treatments in cryptogenic stroke patients with patent foramen ovale: A randomized clinical trial.
    Shariat A; Yaghoubi E; Farazdaghi M; Aghasadeghi K; Borhani Haghighi A
    J Res Med Sci; 2013 Feb; 18(2):94-8. PubMed ID: 23914208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.